ELV241018P630000
- 65.13
- 0.000.00%
Elevance Health Newsroom
Three Events That Shook Health Insurers This Week
Over 60% of Companies That Reported Earnings This Week Beat EPS and Revenue Estimates - Earnings Scorecard
A Quick Look at Today's Ratings for Elevance Health(ELV.US), With a Forecast Between $520 to $622
Elevance Health Insider Sold Shares Worth $3,205,182, According to a Recent SEC Filing
Elevance Health(ELV.US) Officer Sells US$3.21 Million in Common Stock
$Elevance Health(ELV.US)$ Officer Kendrick Charles Morgan JR sold 7,417 shares of common stock on Oct 18, 2024 at an average price of $432.14 for a total value of $3.21 million.Source: Announcement
Elevance, CVS, UnitedHealth Struggle With Rising Medical Costs After COVID-19 Medicaid Policy Ends
These Analysts Cut Their Forecasts On Elevance Health Following Q3 Earnings
Elevance Health Shares Are Trading Lower After Argus Research Downgraded the Stock From Buy to Hold and Multiple Firms Cut Their Respective Price Targets.
Argus Research Downgrades Elevance Health to Hold
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), AbbVie (ABBV) and Elevance Health (ELV)
Elevance Health Price Target Cut to $478.00/Share From $585.00 by RBC Capital
Zacks Industry Outlook Highlights Elevance Health, Doximity and HealthEquity
Elevance Health Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
A Quick Look at Today's Ratings for Elevance Health(ELV.US), With a Forecast Between $520 to $625
Elevance Health Is Maintained at Overweight by Cantor Fitzgerald
Cantor Fitzgerald Maintains Overweight on Elevance Health, Lowers Price Target to $485
Elevance Health Analyst Ratings
Truist Cuts Price Target on Elevance Health to $520 From $620, Keeps Buy Rating
Analysts Are Bullish on Top Healthcare Stocks: Tenaya Therapeutics (TNYA), Elevance Health (ELV)
Earnings Call: Elevance Health Lowers Outlook Amid Medicaid Challenges